Known targets — ChEMBL curated mechanism
ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4
The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.90 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.90 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.90 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.90 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.61 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.60 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.57 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | KDM5C | P41229 | 3/20 | 0.53 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinic Acid SCHEMBL30153748 | 1.00 | LMNA (0.90) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| Succinic Acid SCHEMBL29896378 | 1.00 | LMNA (0.90) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| Succinic Acid SCHEMBL475082 | 1.00 | — | — | |
| Succinic Acid SCHEMBL29749497 | 1.00 | LMNA (0.90) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| Succinic Acid SCHEMBL9471553 | 0.95 | LMNA (0.82) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| Succinic Acid SCHEMBL9420930 | 0.95 | LMNA (0.82) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| Succinic Acid SCHEMBL10992110 | 0.95 | LMNA (0.82) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| Succinic Acid SCHEMBL18689432 | 0.95 | LMNA (0.82) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| Succinic Acid SCHEMBL10992114 | 0.95 | LMNA (0.82) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 | |
| Succinic Acid SCHEMBL28297795 | 0.95 | LMNA (0.82) | LMNAEGLN1ALKBH5SUCNR1SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240050917-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | FIRMENICH SA (CH) | 2024-02-15 | — | — | US | claimed |
| US-20240050330-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | FIRMENICH SA (CH) | 2024-02-15 | — | — | US | claimed |
| EP-4196257-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | Firmenich SA (CH) | 2023-06-21 | — | — | EP | claimed |
| EP-4178715-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | Firmenich SA (CH) | 2023-05-17 | — | — | EP | claimed |
| WO-2022136008-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | FIRMENICH SA (CH) | 2022-06-30 | — | — | WO | claimed |
| WO-2022136007-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | FIRMENICH SA (CH) | 2022-06-30 | — | — | WO | claimed |
| CN-112280530-B | Sealant for lining sliding sleeve sealing system and preparation method thereof | 海隆石油产品技术服务（上海）有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-112280530-A | Sealant for lining sliding sleeve sealing system and preparation method thereof | 海隆石油产品技术服务（上海）有限公司 | 2021-01-29 | — | — | CN | claimed |
| EP-1488846-B1 | Composite semipermeable membrane, and production process thereof | TORAY INDUSTRIES (JP) | 2013-03-13 | — | — | EP | claimed |
| US-7279097-B2 | Composite semipermeable membrane, and production process thereof | TORAY INDUSTRIES, INC. (JP) | 2007-10-09 | — | — | US | claimed |
| US-20040256309-A1 | Composite semipermeable membrane, and production process thereof | TORAY INDUSTRIES, INC. (JP) | 2004-12-23 | — | — | US | claimed |
| EP-1488846-A1 | Composite semipermeable membrane, and production process thereof | TORAY INDUSTRIES, INC. (JP) | 2004-12-22 | — | — | EP | claimed |
| US-6075139-A | ADDING DROPWISE A WATER IMMISCIBLE ORGANIC SOLVENT CONTAINING A BIFUNCTIONAL ACIDIC REACTANT TO AQUEOUS SOLUTION OF SUCROSE, AND MAINTAINING REACTION UNTIL SUCROSE ESTER OLIGOMER OR POLYMER IS PRODUCED AT INTERFACE | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2000-06-13 | — | — | US | claimed |
| WO-1998003528-A1 | LINEAR AND CYCLIC SUCROSE REACTION PRODUCTS, THEIR PREPARATION AND THEIR USE | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1998-01-29 | — | — | WO | claimed |
| US-5141747-A | Repairing the tympanic membrane with coupled and modified collagen using radiation and lysine-reactive compounds; nontoxic; tensile strength | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-08-25 | — | — | US | claimed |
| US-4567210-A | 4-ACYL-2-PHENYL-1-OXA-3,4-DIAZOL-5-ONES AS BLOWING AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1986-01-28 | — | — | US | claimed |
| CN-122028974-A | Ribonucleic acid-based microcapsules | 弗门尼舍有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-117651742-B | Compounds using natural pigments | DIC株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-3956298-A | POLYMER STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
| US-3931142-A | Heterocyclic containing disazo compounds | CIBA-GEIGY AG (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240050330-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | CHMP4B, EXOSC9, F5 | LMNA 2020/4885EGLN1 3497/4885ALKBH5 642/4885 |
| US-20240050917-A1 | PROCESS FOR PREPARING POLYESTER MICROCAPSULES | CHMP4B, EXOSC9, F5 | LMNA 2020/4885EGLN1 3497/4885ALKBH5 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.